M&T Bank
TAK icon

M&T Bank’s Takeda Pharmaceutical TAK Stock Holding History

M&T Bank’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
85,032
+32,514
+62% +$538K ﹤0.01% 770
2026
Q1 		$973K Sell
52,518
-9,044
-15% -$159K ﹤0.01% 859
2025
Q4 		$960K Sell
61,562
-6,953
-10% -$99.4K ﹤0.01% 877
2025
Q3 		$1M Sell
68,515
-6,242
-8% -$92.7K ﹤0.01% 774
2025
Q2 		$1.16M Buy
74,757
+33,337
+80% +$493K ﹤0.01% 800
2025
Q1 		$616K Buy
41,420
+2,906
+8% +$40.7K ﹤0.01% 990
2024
Q4 		$510K Sell
38,514
-4,277
-10% -$58.8K ﹤0.01% 1159
2024
Q3 		$608K Buy
42,791
+2,002
+5% +$28.4K ﹤0.01% 1097
2024
Q2 		$528K Sell
40,789
-445
-1% -$5.89K ﹤0.01% 1097
2024
Q1 		$573K Buy
41,234
+7,310
+22% +$106K ﹤0.01% 1088
2023
Q4 		$484K Sell
33,924
-10,604
-24% -$150K ﹤0.01% 1139
2023
Q3 		$689K Buy
44,528
+4,187
+10% +$64.8K ﹤0.01% 956
2023
Q2 		$634K Sell
40,341
-858
-2% -$14.1K ﹤0.01% 1028
2023
Q1 		$679K Buy
41,199
+14,266
+53% +$227K ﹤0.01% 1001
2022
Q4 		$420K Buy
+26,933
New +$376K ﹤0.01% 1175
2022
Q3 		– Sell
-10,464
Closed -$63K – 1672
2022
Q2 		$63K Buy
+10,464
New +$149K ﹤0.01% 1498
2021
Q1 		– Sell
-10,549
Closed -$192K – 1708
2020
Q4 		$192K Sell
10,549
-7,789
-42% -$137K ﹤0.01% 1527
2020
Q3 		$327K Sell
18,338
-5,858
-24% -$107K ﹤0.01% 1191
2020
Q2 		$434K Sell
24,196
-4,068
-14% -$73K ﹤0.01% 1001
2020
Q1 		$429K Sell
28,264
-1,668
-6% -$30.2K ﹤0.01% 973
2019
Q4 		$591K Buy
29,932
+3,896
+15% +$74.5K ﹤0.01% 793
2019
Q3 		$448K Sell
26,036
-1,520
-6% -$26.3K ﹤0.01% 1012
2019
Q2 		$488K Buy
27,556
+354
+1% +$6.44K ﹤0.01% 979
2019
Q1 		$554K Buy
+27,202
New +$547K ﹤0.01% 911

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

M&T Bank's TAK Position: Q2 2026 in Review

M&T Bank increased its Takeda Pharmaceutical (TAK) stake by 62% in Q2 2026, buying an estimated $538K and bringing the position to 85,032 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #770.

M&T Bank first reported a position in TAK in Q1 2019 and has held it in 24 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • M&T Bank held 85,032 shares of Takeda Pharmaceutical worth $1.36M as of Q2 2026.
  • M&T Bank bought 32,514 Takeda Pharmaceutical shares in Q2 2026, an estimated $538K.
  • Takeda Pharmaceutical made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #770 holding.
  • M&T Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 24 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.